Cite
Treisman DM, Li Y, Pierce BR, et al. Sox2. Neurooncol Adv. 2019;1(1):vdz027doi: 10.1093/noajnl/vdz027.
Treisman, D. M., Li, Y., Pierce, B. R., Li, C., Chervenak, A. P., Tomasek, G. J., Lozano, G., Zheng, X., Kool, M., & Zhu, Y. (2019). Sox2. Neuro-oncology advances, 1(1), vdz027. https://doi.org/10.1093/noajnl/vdz027
Treisman, Daniel M, et al. "Sox2." Neuro-oncology advances vol. 1,1 (2019): vdz027. doi: https://doi.org/10.1093/noajnl/vdz027
Treisman DM, Li Y, Pierce BR, Li C, Chervenak AP, Tomasek GJ, Lozano G, Zheng X, Kool M, Zhu Y. Sox2. Neurooncol Adv. 2019 May-Dec;1(1):vdz027. doi: 10.1093/noajnl/vdz027. Epub 2019 Sep 23. PMID: 31763624; PMCID: PMC6860004.
Copy
Download .nbib